To the extent possible under law, AOP-Wiki has waived all copyright and related or neighboring rights to KE:584
Key Event Title
Inhibition, sodium channel
|Level of Biological Organization|
Key Event Components
|sodium channel inhibitor activity||sodium channel protein type 1 subunit alpha||decreased|
|signaling||sodium channel protein type 1 subunit alpha||decreased|
Key Event Overview
AOPs Including This Key Event
|AOP Name||Role of event in AOP||Point of Contact||Author Status||OECD Status|
|sodium channel inhibition 1||MolecularInitiatingEvent||Kellie Fay (send email)||Under Development: Contributions and Comments Welcome|
|sodium channel inhibition 2||MolecularInitiatingEvent||Kellie Fay (send email)||Under Development: Contributions and Comments Welcome|
|sodium channel inhibition 3||MolecularInitiatingEvent||Kellie Fay (send email)||Under Development: Contributions and Comments Welcome|
|Nav1.1 inhibition to population decline||MolecularInitiatingEvent||Kellie Fay (send email)||Under Development: Contributions and Comments Welcome|
Key Event Description
Voltage-gated sodium channels consist of an alpha subunit and auxiliary beta subunits. The alpha subunit is the ion pore-forming component of the channel and is organized into four homologous domains (I- IV), each with six trans-membrane alpha helices (S1-S6). Between the S5 and S6 segments, there is a pore loop which is a primary target for anti-epileptic drugs. The segments between S5 and S6 in each of the four domains create extracellular pore loops. Amino acid changes in the poor loops within domains II and IV determine if the ion channel is sensitive to sodium or calcium ions. Anti-epileptic, anti-arrhythmic and anesthetics all may bind this same site, but their action may be voltage-specific. For example, phenytoin is an ineffective block of hyperpolarized (e.g., -100mV) sodium channels, but is more effective at blocking progressively depolarized potentials (e.g., -80 to -30 mV).
How It Is Measured or Detected
Voltage-clamp recordings of sodium currents is a general means of detection. ToxCast assay NVS_IC_rNaCh_site 2 also measures binding to the sodium channel receptor.
Domain of Applicability
Ragsdale, D.S. and Avoli, M. 1998. Sodium channels as molecular targets for antiepileptic drugs. Brain Research Reviews 26:16-28.
Pless, S.A., Galpin, J.D., Frankel, A., and Ahern, C.A. 2011. Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels. Nat Commun 2:351.